Pediatric Hematology and Oncology

The Division of Pediatric Hematolog and Oncology in the Department of Pediatrics at UT Southwestern Medical Center has a four-fold mission:

  • The diagnosis and care of infants, children, and adolescents with cancer and myriad hematologic disorders
  • The education of medical students, residents, fellows, and other trainees, as well as provision of continuing education to practicing physicians
  • Clinical, translational, and laboratory research aimed at improving and extending our knowledge about blood diseases and cancer
  • Advocacy of our cause on behalf of the patients and families we serve

Under the direction of Stephen X. Skapek, M.D., a team of 26 faculty, 11 fellows, and more than 100 support and administrative staff are dedicated to the fulfillment of that mission.

Excellence in Pediatric Hematology/Oncology Care

As the major program of its kind in North Texas and one of the 10 largest in the United States, the Division provides care in the Pauline Allen Gill Center for Cancer and Blood Disorders, formerly known as the Center for Cancer and Blood Disorders (CCBD), at Children’s Medical Center Dallas to hundreds of patients with uncommon and complex disorders. We also offer outreach that includes educational and consultative resources for primary and referring physicians in the region. For 2013-14 The Children's Gill Center was named among the top Children's Oncology programs the United States by U.S. News & World Report, the highest ranking of any medical subspecialty at Children's. Learn more about the excellence of our patient care.

For 2013-14 the Children’s Oncology Program was named among the top in the United States by U.S. News and World Report.

 

Leadership in Research

The Division of Pediatric Hematology and Oncology is nationally distinguished for its design and conduct of NIH-funded multi-center clinical trials involving childhood cancer, sickle cell disease, and hemorrhagic disorders. Each faculty member participates in joint clinical research projects, particularly involving the Children’s Oncology Group (COG). Our Division is a national leader in clinical research in non-malignant hematology, and we are one of 10 National Heart, Lung and Blood Institute-funded Comprehensive Sickle Cell Centers. We also have several outstanding physician-scientists who are actively engaged in laboratory research. Learn more about our state-of-the-art research.

Education of Future Leaders in Pediatric Hematology/Oncology

Our education mission includes medical students, pediatric residents, and hematology/oncology fellows. The Division also sponsors an innovative summer student internship program for outstanding premedical and medical students. Learn more about our education and training programs